These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 10677373)
1. Mutations in the reduced-folate carrier affect protein localization and stability. Sadlish H; Murray RC; Williams FM; Flintoff WF Biochem J; 2000 Mar; 346 Pt 2(Pt 2):509-18. PubMed ID: 10677373 [TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic domains of the reduced folate carrier are essential for trafficking, but not function. Sadlish H; Williams FM; Flintoff WF Biochem J; 2002 Jun; 364(Pt 3):777-86. PubMed ID: 12049642 [TBL] [Abstract][Full Text] [Related]
3. Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis. Zhang S; Bagshaw R; Hilson W; Oho Y; Hinek A; Clarke JT; Callahan JW Biochem J; 2000 Jun; 348 Pt 3(Pt 3):621-32. PubMed ID: 10839995 [TBL] [Abstract][Full Text] [Related]
4. Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples. Yang R; Sowers R; Mazza B; Healey JH; Huvos A; Grier H; Bernstein M; Beardsley GP; Krailo MD; Devidas M; Bertino JR; Meyers PA; Gorlick R Clin Cancer Res; 2003 Feb; 9(2):837-44. PubMed ID: 12576457 [TBL] [Abstract][Full Text] [Related]
5. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein. Ambasudhan R; Wang X; Jablonski MM; Thompson DA; Lagali PS; Wong PW; Sieving PA; Ayyagari R Genomics; 2004 Apr; 83(4):615-25. PubMed ID: 15028284 [TBL] [Abstract][Full Text] [Related]
6. The reduced folate carrier gene is a novel selectable marker for recombinant protein overexpression. Rothem L; Berman B; Stark M; Jansen G; Assaraf YG Mol Pharmacol; 2005 Sep; 68(3):616-24. PubMed ID: 15939798 [TBL] [Abstract][Full Text] [Related]
7. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. Wang J; Takeuchi T; Tanaka S; Kubo SK; Kayo T; Lu D; Takata K; Koizumi A; Izumi T J Clin Invest; 1999 Jan; 103(1):27-37. PubMed ID: 9884331 [TBL] [Abstract][Full Text] [Related]
8. Characterization of human torsinA and its dystonia-associated mutant form. Liu Z; Zolkiewska A; Zolkiewski M Biochem J; 2003 Aug; 374(Pt 1):117-22. PubMed ID: 12780349 [TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells. Kühnel JM; Chiao JH; Sirotnak FM J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368 [TBL] [Abstract][Full Text] [Related]
10. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex. Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272 [TBL] [Abstract][Full Text] [Related]
11. A single point mutation resulting in an adversely reduced expression of DPM2 in the Lec15.1 cells. Pu L; Scocca JR; Walker BK; Krag SS Biochem Biophys Res Commun; 2003 Dec; 312(3):555-61. PubMed ID: 14680801 [TBL] [Abstract][Full Text] [Related]
12. Alpha 1-antitrypsin nonsense mutation associated with a retained truncated protein and reduced mRNA. Lee J; Novoradovskaya N; Rundquist B; Redwine J; Saltini C; Brantly M Mol Genet Metab; 1998 Apr; 63(4):270-80. PubMed ID: 9635295 [TBL] [Abstract][Full Text] [Related]
13. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity. Wang Y; Kelly MA; Cowan TM; Longo N Hum Mutat; 2000; 15(3):238-45. PubMed ID: 10679939 [TBL] [Abstract][Full Text] [Related]
14. Reduced folate carrier polymorphism (80A-->G) and neural tube defects. De Marco P; Calevo MG; Moroni A; Merello E; Raso A; Finnell RH; Zhu H; Andreussi L; Cama A; Capra V Eur J Hum Genet; 2003 Mar; 11(3):245-52. PubMed ID: 12673279 [TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma. Kastrup IB; Worm J; Ralfkiaer E; Hokland P; Guldberg P; Grønbaek K Eur J Haematol; 2008 Jan; 80(1):61-6. PubMed ID: 18028428 [TBL] [Abstract][Full Text] [Related]
16. Loss of membrane targeting of Vangl proteins causes neural tube defects. Iliescu A; Gravel M; Horth C; Kibar Z; Gros P Biochemistry; 2011 Feb; 50(5):795-804. PubMed ID: 21142127 [TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the karmellae-inducing signal in Hmg1p, a yeast HMG-CoA reductase isozyme. Profant DA; Roberts CJ; Wright RL Yeast; 2000 Jun; 16(9):811-27. PubMed ID: 10861905 [TBL] [Abstract][Full Text] [Related]
18. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes]. Zhang DL; Ji L; Li YD Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601 [TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of a novel endoplasmic reticulum localized G-patch domain protein, IER3IP1. Yiu WH; Poon JW; Tsui SK; Fung KP; Waye MM Gene; 2004 Aug; 337():37-44. PubMed ID: 15276200 [TBL] [Abstract][Full Text] [Related]
20. A temperature-sensitive splicing mutation in the bimG gene of Aspergillus produces an N-terminal fragment which interferes with type 1 protein phosphatase function. Hughes M; Arundhati A; Lunness P; Shaw PJ; Doonan JH EMBO J; 1996 Sep; 15(17):4574-83. PubMed ID: 8887549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]